Clinical Trial Update: Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of bevacizumab for inflammatory breast cancer and locally advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED